Nekkar ASA (LON:0MQC)
11.50
+0.10 (0.88%)
At close: Dec 3, 2025
Nekkar ASA Revenue
Nekkar ASA had revenue of 123.70M NOK in the quarter ending September 30, 2025, a decrease of -11.01%. This brings the company's revenue in the last twelve months to 555.00M, down -10.50% year-over-year. In the year 2024, Nekkar ASA had annual revenue of 623.51M with 8.42% growth.
Revenue (ttm)
555.00M NOK
Revenue Growth
-10.50%
P/S Ratio
2.15
Revenue / Employee
4.30M NOK
Employees
129
Market Cap
88.79M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 623.51M | 48.42M | 8.42% |
| Dec 31, 2023 | 575.09M | 187.58M | 48.41% |
| Dec 31, 2022 | 387.50M | -92.48M | -19.27% |
| Dec 31, 2021 | 479.98M | 120.52M | 33.53% |
| Dec 31, 2020 | 359.47M | 92.85M | 34.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |